Masticatory muscle index for indicating skeletal muscle mass in patients with head and neck cancer

被引:17
|
作者
Chang, Sheng-Wei [1 ]
Tsai, Yuan-Hsiung [1 ]
Hsu, Cheng-Ming [2 ]
Huang, Ethan I. [2 ]
Chang, Geng-He [2 ]
Tsai, Ming-Shao [2 ]
Tsai, Yao-Te [2 ]
机构
[1] Chang Gung Mem Hosp, Dept Radiol, Chiayi, Taiwan
[2] Chang Gung Mem Hosp, Dept Otorhinolaryngol Head & Neck Surg, Chiayi, Taiwan
来源
PLOS ONE | 2021年 / 16卷 / 05期
关键词
SARCOPENIC OBESITY; BODY-COMPOSITION; PREVALENCE; RADIOTHERAPY; INFLAMMATION; PREDICTOR; MORTALITY; TOXICITY;
D O I
10.1371/journal.pone.0251455
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background A typical assessment for sarcopenia involves the use of abdominal computed tomography (CT) for calculating the skeletal muscle index (SMI) at the level of the third lumbar vertebra (L3). However, abdominal CT is not regularly performed on patients with head and neck cancer (HNC). We investigated whether masticatory SMI (M-SMI) measurements based on head and neck CT scans can be used to conduct sarcopenia assessments by evaluating whether M-SMI is correlated with L3-SMI. Methods Abdominal and head and neck CT images of patients with trauma (n = 50) and HNC (n = 52) were analyzed retrospectively. Both manual delineation and threshold selection methods were used to measure cross-sectional areas of masticatory muscles and those of muscles at the L3 level on CT images. Muscle cross-sectional areas were normalized to height squared to calculate SMI, and a multivariate linear regression model was established to evaluate the correlation between the M-SMI and L3-SMI. Receiver operating characteristic curve analysis was used to assess the ability of the M-SMI to identify sarcopenia, and Cox logistic regression was used to identify predictors of sarcopenia. Results Patients with HNC had significantly lower M-SMI and L3-SMI than did patients with trauma (p = 0.011 and 0.03, respectively). M-SMI and L3-SMI were strongly correlated (r = 0.901, p < 0.001); in the multivariate model that included sex, the correlation was stronger (r = 0.913, p < 0.001). The associations of sarcopenia with a lower M-SMI (p < 0.001), male sex (p = 0.028), and advanced age (p = 0.011) were significant, and multivariate logistic analysis demonstrated that an M-SMI of <5.5 was an independent predictor of sarcopenia (hazard ratio = 5.37, p < 0.001). Conclusions M-SMI assessment in routine head and neck CT scans is feasible and can be an alternative for detecting sarcopenia in patients with HNC.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] Masticatory muscle index for indicating skeletal muscle mass in patients with head and neck cancer (vol 19, e0304880, 2024)
    Chang, Sheng-Wei
    Tsai, Yuan-Hsiung
    Hsu, Cheng-Ming
    Huang, Ethan I.
    Chang, Geng-He
    Tsai, Ming-Shao
    Tsai, Yao-Te
    PLOS ONE, 2024, 19 (05):
  • [2] Unveiling the relation between swallowing muscle mass and skeletal muscle mass in head and neck cancer patients
    Hurtado-Oliva, Javier
    Nunez-Miranda, Lucy
    Zwart, Aniek T.
    Vister, Jeroen
    Plaat, Boudewijn E. C.
    Steenbakkers, Roel J. H. M.
    van der Hoorn, Anouk
    Wegner, Inge
    Halmos, Gyorgy B.
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2025,
  • [3] Efficacy of head and neck computed tomography for skeletal muscle mass estimation in patients with head and neck cancer
    Jung, Ah Ra
    Roh, Jong-Lyel
    Kim, Jae Seung
    Choi, Seung-Ho
    Nam, Soon Yuhl
    Kim, Sang Yoon
    ORAL ONCOLOGY, 2019, 95 : 95 - 99
  • [4] Skeletal muscle mass measurements using head and neck CT imaging in head and neck cancer patients
    de Bree, Remco
    Swartz, Justin E.
    Bril, Sandra
    Chargi, Najiba
    Wegner, Inge
    Smid, Ernst J.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : 72 - 73
  • [5] Feasibility of using head and neck CT imaging to assess skeletal muscle mass in head and neck cancer patients
    Swartz, Justin E.
    Pothen, Ajit J.
    Wegner, Inge
    Smid, Ernst J.
    Swart, Karin M. A.
    de Bree, Remco
    Leenen, Loek P. H.
    Grolman, Wilko
    ORAL ONCOLOGY, 2016, 62 : 28 - 33
  • [6] Low skeletal muscle mass predicts frailty in elderly head and neck cancer patients
    C. D. A. Meerkerk
    N. Chargi
    P. A. de Jong
    F. van den Bos
    R. de Bree
    European Archives of Oto-Rhino-Laryngology, 2022, 279 : 967 - 977
  • [7] Low skeletal muscle mass predicts frailty in elderly head and neck cancer patients
    Meerkerk, C. D. A.
    Chargi, N.
    de Jong, P. A.
    van den Bos, F.
    de Bree, R.
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2022, 279 (02) : 967 - 977
  • [8] Impact of Low Skeletal Muscle Mass on the Prognosis of Patients with Head and Neck Cancer Treated Nonsurgically
    Iwasa, Yoh-Ichiro
    Kitoh, Ryosuke
    Hiramatsu, Ken
    Sugiyama, Kenjiro
    Watanabe, Kizuki
    Yasukawa, Rika
    Shinagawa, Jun
    Miyajima, Hiroki
    Yokota, Yoh
    Kobayashi, Masafumi
    Kitano, Tomohiro
    Mori, Kentaro
    Takumi, Yutaka
    ORL-JOURNAL FOR OTO-RHINO-LARYNGOLOGY HEAD AND NECK SURGERY, 2023, 85 (01): : 36 - 43
  • [9] Skeletal muscle mass at C3 may not be a strong predictor for skeletal muscle mass at L3 in sarcopenic patients with head and neck cancer
    Yoon, Joon-Kee
    Jang, Jeon Yeob
    An, Young-Sil
    Lee, Su Jin
    PLOS ONE, 2021, 16 (07):
  • [10] Validation of skeletal muscle mass assessment at the level of the third cervical vertebra in patients with head and neck cancer
    Bril, S., I
    Chargi, N.
    Wendrich, A. W.
    Wegner, I
    Bol, G. H.
    Smid, E. J.
    de Jong, P. A.
    Devriese, L. A.
    de Bree, R.
    ORAL ONCOLOGY, 2021, 123